Intel has steadied at $107.92, clawing back from the brief break below $100 flagged in the June 8 report, yet the fundamental tension that has defined this stock for weeks remains entirely unresolved: the price still trades well above where analysts think it belongs.
The most notable development in positioning is how aggressively shorts have retreated. Short interest dropped nearly 9% on the week to 2.7% of the free float — the lowest reading in the 30-day window and a continuation of the steady unwind from the roughly 3% level seen through May. That's not a crowded short book by any measure. The borrow market confirms the lack of conviction on the short side: cost to borrow is a negligible 0.49%, and availability is essentially unlimited — nearly 5 billion shares remain available to lend, a pool so deep it barely registers as a constraint. There is no squeeze pressure and no sign that new shorts are building. Options tell a slightly more nuanced story. The put/call ratio has eased to 1.005, now running about 1.2 standard deviations below its 20-day average of 1.06 — meaning the heavy defensive skew that dominated through much of May has largely unwound. Hedging demand has come off. Neither the short book nor the options market is positioned for a sharp move lower right now.
The Street remains the real friction point, and the gap has barely closed. The mean analyst price target is $92.17 — Intel at $107.92 is still trading 17% above consensus, even after a 13.6% slide over the past month. The bulk of coverage stays at Hold-equivalent, with Barclays and Wells Fargo both raising targets on June 1 (to $100 and $110 respectively) while keeping neutral ratings — a posture that says "we acknowledge the move but won't chase it." Only Citigroup ($130) and Benchmark ($140), both updated in mid-May, have targets above the current price. The EPS momentum factor score is genuinely striking at the 97th percentile on a 90-day basis, reflecting the Q1 beat and guidance raise that drove April's 26% single-day surge. But value metrics undercut the optimism: the PE multiple has compressed from near-97x to 84x over the past month, yet that's still a demanding number for a company whose foundry business won't reach profitability until 2027. The EV/EBIT factor score sits in the 3rd percentile — effectively the bottom of the universe.
The bull and bear cases are unusually well-defined here. Bulls point to the AI infrastructure tailwind, the data center revenue surge of 18% year-on-year in Q1, and the foundry catalyst that emerged this week — reports that Google and Nvidia are evaluating Intel as a backup chip manufacturer. That's the thesis crystallised in a single headline. Bears note the continued heavy foundry investment, limited direct AI chip exposure relative to AMD and Nvidia, and a balance sheet absorbing significant cash burn. AMD itself fell 8.8% on the week and NXP Semiconductors dropped 8.1%, suggesting sector-wide pressure rather than Intel-specific weakness in this latest leg down.
The CFO sold $2 million of stock on June 1 at $109.82, following a routine award — low significance in isolation, but worth noting given the proximity to the current price. The 90-day net insider position is modestly positive at roughly $9.8 million, primarily from awards, so there's no strong directional read from the insider register.
Q2 earnings land July 23. The last print produced a 26% single-day rally and a 45% five-day move — the kind of reaction that resets the narrative entirely. The question heading into that date is whether the foundry validation story, if confirmed, closes any of the gap between where analysts have their targets and where the stock is already trading.
See the live data behind this article on ORTEX.
Open INTC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
